Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, an

Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, an

Item

http://www.wikidata.org/entity/Q33342291

Q33342291

about

E-cigarette use results in suppression of immune and inflammatory-response genes in nasal epithelial cells similar to cigarette smoke Neutrophil kinetics in health and disease.Erythrocytic mobilization enhanced by the granulocyte colony-stimulating factor is associated with reduced anthrax-lethal-toxin-induced mortality in mice.Side effects of therapy of hepatitis C and their management.Engrafted human cells generate adaptive immune responses to Mycobacterium bovis BCG infection in humanized mice.Systemic responses during local viral infections: type I IFNs sound the alarm.Novel strategies to fight Candida species infection.Interferon beta-1a in ulcerative colitis: a placebo controlled, randomised, dose escalating study.PSGL-1 and mTOR regulate translation of ROCK-1 and physiological functions of macrophages.Neutrophil biology and the next generation of myeloid growth factors.How I treat mucormycosis.Cytokine therapies in HIV-1 infection: present and future.Cytokines and fungal infections.Granulocyte transfusions in children and adults with hematological malignancies: benefits and controversies Differential constitutive and cytokine-modulated expression of human Toll-like receptors in primary neutrophils, monocytes, and macrophages.Strategies to enhance immune function in hematopoietic transplantation recipients who have fungal infections.Immunomodulatory therapy in yeast infections.Combination therapeutic approaches for the management of invasive aspergillosis in organ transplant recipients.Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease.Novel strategies for the prevention and treatment of Candida infections: the potential of immunotherapy.Antiviral therapy in HCV-infected decompensated cirrhotics.Gamma interferon enhances internalization and early nonoxidative killing of Salmonella enterica serovar Typhimurium by human macrophages and modifies cytokine responses.Chronic Disseminated Salmonellosis in a Patient with Interleukin- 12p40 Deficiency.The cytokine, granulocyte-macrophage colony-stimulating factor (GM-CSF), can deliver Bcl-XL as an extracellular fusion protein to protect cells from apoptosis and retain differentiation induction.Efficacy of liposomal amphotericin B combined with gamma interferon or granulocyte-macrophage colony-stimulating factor for treatment of systemic zygomycosis in mice.Milder clinical hyperimmunoglobulin E syndrome phenotype is associated with partial interleukin-17 deficiency.Potential of albumin nanoparticles as carriers for interferon gamma.Recent Advancements in Combinational Antifungal Therapy and Immunotherapy

P2860

Q28385513-53B62D4F-39CE-455E-914D-89FB00615BE9 Q34092240-2DF87989-296D-401E-A051-97F61787D0C1 Q34482648-7B8F32CD-BDEB-4755-B594-5961D0E723E7 Q34984142-A0992F22-A478-49A6-A8C6-C686B9A5EBFE Q35061752-AC7ED561-F51F-441D-B5A3-58F68B4AA553 Q35186341-85BF692B-EC33-44E9-B8F3-12D38C226583 Q35406737-417AEE29-A5AF-40CB-A408-45F7E9EEAF9E Q35595986-F4335221-47B8-4205-9E06-D8BEB783DED0 Q35612494-6DF1A742-EC4D-4340-829F-E4C9D7C7CBF1 Q35653712-98173988-F26C-47E0-9A96-2E7757303F56 Q35797637-EA61B252-77EA-4923-ACBC-344E12900343 Q35917144-170A3E43-B27D-4980-B6C1-8A9736AFB607 Q36139494-A6369ADF-F1A5-48D0-A377-1F98D7D446FE Q36286585-266AB31C-AF0A-4F8F-B41B-98B1A8356463 Q36389463-B43A20F0-609D-41E0-85C9-C1AEA6DFA121 Q36568458-D77135AF-74A3-4A91-8692-A9B535972E27 Q36723814-11BAEFA9-D9BD-4961-8C24-4657BBA918D2 Q37078394-A25F7F0D-239B-4488-8EBA-45E0F047E5CD Q37443277-1D3397DF-C01E-4ECF-BDE3-7C548F6D7799 Q37763270-020BFAB3-CEC2-490B-BDEC-30B7805FEBF8 Q37792718-20A52B47-A495-4AC3-A892-BD94CC960DC4 Q39029194-0FAB6BF4-5C8D-457A-9BBE-863C3C969E42 Q40127885-B2ADFC94-565B-4580-A399-76A96F1F4B89 Q40168876-9708622E-C0A9-4979-B368-24C22AD0378C Q42095363-5C09B367-DD58-465C-982D-58118FF63181 Q45819568-CD91695E-1F73-469D-A5DC-F9C11F03C633 Q46437936-1C3A9C90-A1B1-4DB0-8754-DD7703DDC474 Q57705351-4F4B8324-6455-43DC-93D3-CC0D3A5F7F85

P2860

Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, an

Item

http://www.wikidata.org/entity/Q33342291

description

2002 nî lūn-bûn

@nan

2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu